Bavarian Nordic A/S (0DPB)
LSE
Real-time Data
07:00 AM
Day's Range
211.0052 wk Range
171.55Overview - 0DPB - Bavarian Nordic A/S
Key Statistics
Valuation
Enterprise Value
8.63B
P/E (Trailing)
‪15.05‬
PEG Ratio
‪-0.16‬
Price / Sales (TTM)
‪3.59‬
Price / Book
‪1.65‬
EV / EBITDA
‪5.18‬
Profitability
Gross Margin
‪44.82%‬
Profit Margin
‪19.45%‬
Operating Margin
‪22.95%‬
Return on Assets
‪5.87%‬
Return on Equity
‪12.99%‬
Ownership
Shares Outstanding
77.14M
Float
75.71M
Held by Insiders
‪0.09%‬
Held by Institutions
‪30.60%‬
Price stats
Beta
‪1.29‬
50-Day Avg
‪182.14‬
200-Day Avg
‪206.23‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0DPB - Bavarian Nordic A/S
Peers - 0DPB - Bavarian Nordic A/S
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
Profile Summary - 0DPB - Bavarian Nordic A/S
About
Bavarian Nordic A/S is a Danish biotechnology company specializing in the research, development, manufacturing, and commercialization of innovative vaccines based on viral vector technologies. Headquartered in Hellerup, Denmark, with manufacturing facilities in Denmark and Switzerland, and R&D sites in Germany plus…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
